CYTOKINETICS INC — Investor Relations & Filings

Cytokinetics is a late-stage biopharmaceutical company that specializes in muscle biology and the mechanics of muscle performance. The company focuses on discovering, developing, and commercializing small molecule drug candidates engineered to impact muscle function and contractility. Its primary therapeutic areas include debilitating cardiovascular and neuromuscular diseases, such as heart failure and hypertrophic cardiomyopathy (HCM). Cytokinetics' pipeline is centered on developing first-in-class muscle activators and next-in-class muscle inhibitors, with a significant focus on cardiac myosin inhibitors. The company's mission is to improve the healthspan of patients living with conditions of impaired muscle function.